Immune cell phenotyping of clear cell renal cell carcinoma.

Mazyar Ghanaat(Memorial Sloan Kettering Cancer Center), A. Ari Hakimi(Penn State Milton S. Hershey Medical Center), Almedina Redzematovic(Memorial Sloan Kettering Cancer Center), James J. Hsieh(Memorial Sloan Kettering Cancer Center), Paul Russo(Memorial Sloan Kettering Cancer Center), Jonathan Coleman(Memorial Sloan Kettering Cancer Center), Ming Liu(Chinese Academy of Medical Sciences & Peking Union Medical College), Ming Li(Air Force Medical University), Brandon J. Manley(Moffitt Cancer Center), Maria F. Becerra(Memorial Sloan Kettering Cancer Center), Mahyar Kashan(Memorial Sloan Kettering Cancer Center)
Journal of Clinical Oncology
February 20, 2017
10.1200/jco.2017.35.6_suppl.511
Cited by 1

Related Papers

Tumor mutational load predicts survival after immunotherapy across multiple cancer types
|Nature Genetics|2019|4.4k
Tumor immune microenvironment characterization in clear cell renal cell carcinoma identifies prognostic and immunotherapeutically relevant messenger RNA signatures
|Genome biology|2016|1k
Tracking Cancer Evolution Reveals Constrained Routes to Metastases: TRACERx Renal
|Cell|2018|883
The Somatic Genomic Landscape of Chromophobe Renal Cell Carcinoma
|Cancer Cell|2014|867
An Integrated Metabolic Atlas of Clear Cell Renal Cell Carcinoma
|Cancer Cell|2016|855